TumorGlow Intraoperative Molecular Imaging (IMI)

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

August 14, 2024

Primary Completion Date

January 14, 2026

Study Completion Date

January 14, 2026

Conditions
Tumor, Solid
Interventions
DRUG

Indocyanine Green

The investigational drug is indocyanine green, single dose between 1-5 mg/kg diluted into sterile water for intravenous (IV) injection up to 5 days prior to resection surgery. The actual dose and timing from dose to imaging will be determined based on tumor type.

Trial Locations (1)

19104

RECRUITING

University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER